With the increase in the TyG index in both crude and adjusted models, the risks of multi-vessel CAD among the NGR, pre-DM, and DM non-insulin Rx groups are more significant than that among DM insulin Rx group (P for interaction = 0.008). Here, INS is linked to diabetes mellitus.